Jim Simons's position in ORIC Pharmaceuticals is currently worth $1.84 Million. That's 0.00% of their equity portfolio (1894th largest holding). The first ORIC Pharmaceuticals trade was made in Q4 2021. Since then Jim Simons bought shares four more times and sold shares on four occasions. The stake costed the investor $1.29 Million, netting the investor a gain of 43% so far.